Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Weiss

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
FEBS Letters|January 24, 2007
From sequence to antibody: genetic immunisation is suitable to generate antibodies against a rare plant membrane protein, the KAT 1 channelRenate Gehwolf, Richard Weiss, Maximilian Gabler, et al.
Journal of Biotechnology|March 7, 2006
Protective efficiency of dendrosomes as novel nano-sized adjuvants for DNA vaccination against birch pollen allergyNariman Aghaei Bandbon Balenga, Farnaz Zahedifard, Richard Weiss, et al.
Vaccine|December 9, 2019
Mast cells and γδ T cells are largely dispensable for adaptive immune responses after laser-mediated epicutaneous immunizationIsabella A Joubert, Daniel Kovacs, Sandra Scheiblhofer, et al.
Seminars in Arthritis and Rheumatism|February 10, 2019
Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for United States women at increased risk of fractureMickael Hiligsmann, Setareh A Williams, Lorraine A Fitzpatrick, et al.
Biomed Research International|November 1, 2013
The fold variant BM4 is beneficial in a therapeutic Bet v 1 mouse modelUlrike Pichler, Claudia Asam, Richard Weiss, et al.
Seminars in Arthritis and Rheumatism|March 13, 2020
Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy in women at increased risk of fracture: A US payer perspectiveMickael Hiligsmann, Setareh A Williams, Lorraine A Fitzpatrick, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|October 10, 2021
Ultrasound-Enhancing Agents and Associated Adverse Reactions: A Potential Connection to the COVID-19 Vaccines?Meshal Soni, Michelle McGovern, Ron Jacob, et al.
Molecular Immunology|October 31, 2006
Gene gun immunization with clinically relevant allergens aggravates allergen induced pathology and is contraindicated for allergen immunotherapySandra Scheiblhofer, Angelika Stoecklinger, Christina Gruber, et al.
Vaccine|August 20, 2013
The influence of antigen targeting to sub-cellular compartments on the anti-allergic potential of a DNA vaccineEsther E Weinberger, Almedina Isakovic, Sandra Scheiblhofer, et al.
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesamt Fur Sera Und Impfstoffe) Zu Frankfurt A.M|May 4, 2004
Strategies for the development of safe and effective DNA vaccines for allergy treatmentArnulf Hartl, Richard Weiss, Romana Hochreiter, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
FEBS Letters|January 24, 2007
From sequence to antibody: genetic immunisation is suitable to generate antibodies against a rare plant membrane protein, the KAT 1 channelRenate Gehwolf, Richard Weiss, Maximilian Gabler, et al.
Journal of Biotechnology|March 7, 2006
Protective efficiency of dendrosomes as novel nano-sized adjuvants for DNA vaccination against birch pollen allergyNariman Aghaei Bandbon Balenga, Farnaz Zahedifard, Richard Weiss, et al.
Vaccine|December 9, 2019
Mast cells and γδ T cells are largely dispensable for adaptive immune responses after laser-mediated epicutaneous immunizationIsabella A Joubert, Daniel Kovacs, Sandra Scheiblhofer, et al.
Seminars in Arthritis and Rheumatism|February 10, 2019
Cost-effectiveness of sequential treatment with abaloparatide vs. teriparatide for United States women at increased risk of fractureMickael Hiligsmann, Setareh A Williams, Lorraine A Fitzpatrick, et al.
Biomed Research International|November 1, 2013
The fold variant BM4 is beneficial in a therapeutic Bet v 1 mouse modelUlrike Pichler, Claudia Asam, Richard Weiss, et al.
Seminars in Arthritis and Rheumatism|March 13, 2020
Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy in women at increased risk of fracture: A US payer perspectiveMickael Hiligsmann, Setareh A Williams, Lorraine A Fitzpatrick, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|October 10, 2021
Ultrasound-Enhancing Agents and Associated Adverse Reactions: A Potential Connection to the COVID-19 Vaccines?Meshal Soni, Michelle McGovern, Ron Jacob, et al.
Molecular Immunology|October 31, 2006
Gene gun immunization with clinically relevant allergens aggravates allergen induced pathology and is contraindicated for allergen immunotherapySandra Scheiblhofer, Angelika Stoecklinger, Christina Gruber, et al.
Vaccine|August 20, 2013
The influence of antigen targeting to sub-cellular compartments on the anti-allergic potential of a DNA vaccineEsther E Weinberger, Almedina Isakovic, Sandra Scheiblhofer, et al.
Arbeiten Aus Dem Paul-Ehrlich-Institut (Bundesamt Fur Sera Und Impfstoffe) Zu Frankfurt A.M|May 4, 2004
Strategies for the development of safe and effective DNA vaccines for allergy treatmentArnulf Hartl, Richard Weiss, Romana Hochreiter, et al.
Pageof 12